Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

First-Line Treatment with Rituximab Combined with Intravenous or Oral Fludarabine for Patients with Extranodal Mucosa Associated Lymphoid Tissue (MALT) Lymphoma.

Antonio Salar, MD, PhD, Eva Domingo-Domènech, MD, Cristina Estany, MD, Miguel Canales, MD, PhD, Octavio Servitge, MD, Fernando Gallardo, MD, PhD, Guadalupe Fraile, Carlos Montalbán, PHD

Blood (2008) 112 (11): 2007.

https://doi.org/10.1182/blood.V112.11.2007.2007

Published: 2008

Journal Articles

Rituximab Combined with Intravenous or Oral Fludarabine for Previously Untreated Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients.

Antonio Salar, MD, Eva Domingo-Domenech, Cristina Estany, Miguel Canales, MD, Octavio Servitge, Fernando Gallardo, Carmen Pedro, Carlos Montalban

Blood (2007) 110 (11): 4450.

https://doi.org/10.1182/blood.V110.11.4450.4450

Published: 2007

Journal Articles

Efficacy of Dose-Dense R-CHOP-14 Chemoimmunotherapy Plus Pegfilgrastim for First-Line Treatment of Diffuse Large B-Cell Lymphoma (DLBCL) in Low Risk Patients: An Interim Analysis of an Open-Label Clinical Trial in Spain. On Behalf of GEL/TAMO (Spanish Group of Lymphoma).

Eva Gonzalez-Barca, Antonio Salar, Joan Bargay, Jose F. Tomas, Miguel A. Canales, Jose M. Moraleda, Maria Jesus Vidal, Secundino Ferrer, Javier Briones, Cristina Estany, Santiago Gardella, Andres Llorente, Dolores Caballero

Blood (2007) 110 (11): 3443.

https://doi.org/10.1182/blood.V110.11.3443.3443

Published: 2007

Journal Articles

Is There a Role for Autologous Stem-Cell Transplantation (ASCT) in Peripheral T-Cell Lymphoma (PTCL)? Final Results of a Prospective Phase II Study from the GELCAB.

Santiago Mercadal, Armando Lopez-Guillermo, Javier Briones, Blanca Xicoy, Carme Pedro, Lourdes Escoda, Cristina Estany, Mireia Camos, Josep-Maria Ribera, Rodrigo Martino, Lluis Colomo, Emili Montserrat

Blood (2006) 108 (11): 3070.

https://doi.org/10.1182/blood.V108.11.3070.3070

Published: 2006

Journal Articles

Intensive Chemotherapy (High-Dose CHOP/ESHAP Regimen) Followed by Autologous Stem-Cell Transplantation (ASCT) in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL). Results of a Prospective Phase II Study from the GELCAB.

Armando Lopez-Guillermo, MD, Santiago Mercadal, MD, Javier Briones, MD, Blanca Xicoy, MD, Carme Pedro, MD, Lourdes Escoda, MD, Cristina Estany, MD, Mireia Camos, MD, Josep Maria Ribera, MD, Rodrigo Martino, MD, Emilio Montserrat, MD

Blood (2005) 106 (11): 2077.

https://doi.org/10.1182/blood.V106.11.2077.2077

Published: 2005

NARROW

First-Line Treatment with Rituximab Combined with Intravenous or Oral Fludarabine for Patients with Extranodal Mucosa Associated Lymphoid Tissue (MALT) Lymphoma.

Rituximab Combined with Intravenous or Oral Fludarabine for Previously Untreated Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients.

Efficacy of Dose-Dense R-CHOP-14 Chemoimmunotherapy Plus Pegfilgrastim for First-Line Treatment of Diffuse Large B-Cell Lymphoma (DLBCL) in Low Risk Patients: An Interim Analysis of an Open-Label Clinical Trial in Spain. On Behalf of GEL/TAMO (Spanish Group of Lymphoma).

Is There a Role for Autologous Stem-Cell Transplantation (ASCT) in Peripheral T-Cell Lymphoma (PTCL)? Final Results of a Prospective Phase II Study from the GELCAB.

Intensive Chemotherapy (High-Dose CHOP/ESHAP Regimen) Followed by Autologous Stem-Cell Transplantation (ASCT) in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL). Results of a Prospective Phase II Study from the GELCAB.

Email alerts

ASH Publications

American Society of Hematology

First-Line Treatment with Rituximab Combined with Intravenous or Oral Fludarabine for Patients with Extranodal Mucosa Associated Lymphoid Tissue (MALT) Lymphoma.

Rituximab Combined with Intravenous or Oral Fludarabine for Previously Untreated Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients.

Efficacy of Dose-Dense R-CHOP-14 Chemoimmunotherapy Plus Pegfilgrastim for First-Line Treatment of Diffuse Large B-Cell Lymphoma (DLBCL) in Low Risk Patients: An Interim Analysis of an Open-Label Clinical Trial in Spain. On Behalf of GEL/TAMO (Spanish Group of Lymphoma).

Is There a Role for Autologous Stem-Cell Transplantation (ASCT) in Peripheral T-Cell Lymphoma (PTCL)? Final Results of a Prospective Phase II Study from the GELCAB.

Intensive Chemotherapy (High-Dose CHOP/ESHAP Regimen) Followed by Autologous Stem-Cell Transplantation (ASCT) in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL). Results of a Prospective Phase II Study from the GELCAB.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only